Michaela Gertz

I'm delighted to announce the launch of the TempoCap Liquidity Indices, which, on a quarterly basis, track the largest European VC-backed exits since January 2020. We are tracking three main types of exits: all cash, cash and shares, and public listings.   We struggled to find this information in a single place or in a comprehensive format, so we decided to compile it ourselves from a range of data sources. Of course, we may have missed some exits, so please don't hesitate to get in touch if we have.   Here are a few notable trends from the data: 🔴 On all cash exits: A limited number of these were above $1 billion in Europe over the last nearly five years - we counted only five. Out of the top 15 cash exits, six were companies from the U.K., four from Germany, three from France, and two from Scandinavia - including the largest, Tink. 14 out of the top 15 exits were to strategics (with only one PE buyer), and 60% of buyers were U.S. companies. The average time to exit from the founding date was ten years. 🔴 On exits for cash and shares: There have been a limited number of these above $1 billion in Europe over the last circa five years, too —we counted only four. The U.K. had five companies out of the top 15, and interestingly, two each came from Poland and Germany, while the largest, Wolt, is Finnish. Again, 60% of buyers were from the U.S. The average time to exit from the founding date is nine years. 🔴 On public listings: Here, all 15 listings were above $1 billion—but some didn't stay above that level post-IPO, and three are no more! Out of the top 15, seven (or nearly half) came from the U.K., three came from Germany, and the largest, UI Path, came from Romania. The average time to IPO from the founding date was 11 years. We have researched various sources to ensure that we have the most accurate information possible, but if you've spotted something that needs to be corrected or a company that needs to be added, please let us know at [email protected].

84

7 kommentarer

Investors attending LSI Europe ‘24 — Check your inbox. We just sent detailed profiles of the 175 startup presenting companies, including: - Capital raised to date - Target capital raise to reach next value inflection point - Key company milestones - LSI-analyst descriptions of the companies  - and more Now, you’ll have a massive head start on identifying right-fit companies to meet with in Portugal. Innovators — this is the strongest investor-startup ratio of any LSI event we’ve ever built. Investors that go to LSI events want to take meetings — and they want to have confidence those meetings will be worthwhile, which is why our team does the work upfront to help them pre-screen and prepare to connect with you onsite. Hundreds of investors, innovators, strategics and more will be arriving at the Epicenter of Medtech in less than 5 weeks. Let’s keep pushing.

56

4 kommentarer

Launch Your Journey with #HypernovaFund! We're thrilled to introduce #Hypernova Fund, the investment vehicle of 1802 Ventures, dedicated to igniting #emergingmarkets in #spaceexploration! At Hypernova Fund, We're building a vibrant #community of #passionateindividuals – #spaceenthusiasts, #industryprofessionals, #innovators, and #thoughtleaders – all united by a #commonvision. We believe #spaceexploration holds the key to solving some of humanity's most pressing challenges. Our #mission is to: Foster #collaboration: We connect #talentedminds across disciplines to spark #groundbreakingideas. Fuel #innovation: We invest in audacious ventures #pushingtheboundaries of what's possible. Champion forward-thinking solutions: We support those who dare to dream big and build a #brighterfuture for ALL. Are you ready to join us? ✔ Potential Clients & Partners: We're actively seeking groundbreaking space ventures to support. Let's discuss how #HypernovaFund can support your mission! Investors: Interested in learning more about investment opportunities with Hypernova Fund? We'd love to chat! Get in touch at [email protected] #SpaceEnthusiasts: Join our network and connect with like-minded individuals. 🌎 https://lnkd.in/dVxTjRTW 🌎 https://lnkd.in/dMGtjYCf 🌎 https://lnkd.in/dx-HdBax Let's propel towards a brighter future, together!

8

2 kommentarer

The Corporate’s Guide to #VC Best Practice. Following a highly successful launch webinar, the #CVC Consortium is pleased to announce the second webinar in the #CVC series, entitled: Date: Monday, 12 August from 12:00 to 14:00 (GMT 2) A snap survey of attendees held during the first webinar found that 67% believed that the main reason corporations begin the venture capital journey is to diversify resources and development efforts, while 45% felt that it was to pursue financial returns. The greatest challenge was perceived to be a lack of understanding or appreciation within the company, of the potential that venture capital investments or start-up investments can provide. Webinar 2 will focus on the crucial role that Corporates have to play in the venture capital space and will unpack the requirements of setting up a CVC from a technical perspective. Register here: https://lu.ma/7g3z2b36 Saskia Nysschens Mark Kleyner Sam Mokorosi Davis Cook Buntu Majaja

10

Private Biotech Fundraising - Maximize Investor Engagement by overpreparing and having a detailed memo in addition to an investor deck – not common, but A approach. Despite a rise in private funding for biotech startups in Q1 2024, the market has largely plateaued since 2022, presenting ongoing challenges for many private biotech firms. To maximize investor engagement and boost your chances of expediting the fundraising process. I strongly advise teams to be exceptionally well-prepared and proactive. Do a Memo too! It's fundamental to have a thorough pitch deck that presents an investment thesis right from the start. However, it’s equally crucial to prepare a comprehensive memo covering all bases—this includes the competitive landscape, distinct advantages, potential risks, fundraising specifics, founders' backgrounds, product details, and market size. Such preparation makes it easier for venture capitalists (VCs) to grasp the business's potential and can accelerate the investment process. Founders should meticulously guide VCs through their diligence by providing comprehensive and easily digestible information. This approach not only streamlines the evaluation process but could also enhance your startup's positioning in the eyes of potential investors. By offering detailed insights, you can help VCs with their due diligence and prevent them from misinterpreting your business's position, leading to a more accurate and favorable assessment. Although not widely adopted, this proactive approach can be very useful in guiding VCs through the diligence process, making it easier and quicker for them to understand and invest in your business.   https://lnkd.in/eRyaEmti   #Privatebiotechfundraising #Bestpractices #Privatebiotechfundraisingguidance

50

1 kommentar